Lipoquality:Database: Difference between revisions
No edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
<h1>Lipoquality</h1> | <h1>Lipoquality</h1> | ||
<h2>Dataset</h2> | |||
Please click '''[[Lipoquality:Resource|here]]''' to access LipoQuality data. | |||
<h2 | |||
Please click [[Lipoquality:Resource|here]] to access LipoQuality data. | |||
;Mouse : C75BL/6J mouse fed with fish-less chow for 2 weeks | ;Mouse : C75BL/6J mouse fed with fish-less chow for 2 weeks | ||
; Organs : Aorta (ApoE KO), Brain, Heart, Kidney, Liver, Lung, Macrophage, Muscle, Plasma, Plasma (ApoE KO), Small intestine, Spleen | ; Organs : Aorta (ApoE KO), Brain, Heart, Kidney, Liver, Lung, Macrophage, Muscle, Plasma, Plasma (ApoE KO), Small intestine, Spleen | ||
| Line 16: | Line 10: | ||
<h2 | <h2>{{Bilingual|脂質記載法|Notation}}</h2> | ||
The style follows the proposal for lipidomics nomenclature | The style follows the proposal for lipidomics nomenclature | ||
(Pauling JK et al. PLOS ONE 2017, PMID 29161304). Please visit [http://prime.psc.riken.jp/Metabolomics_Software/MS-DIAL/index5.html the MS-DIAL page] for more details. | (Pauling JK et al. PLOS ONE 2017, PMID 29161304). Please visit [http://prime.psc.riken.jp/Metabolomics_Software/MS-DIAL/index5.html the MS-DIAL page] for more details. | ||
| Line 128: | Line 122: | ||
! ''non-hydroxy FA''<br/>[N] | ! ''non-hydroxy FA''<br/>[N] | ||
! ''α-hydroxy FA''<br/>[A] | ! ''α-hydroxy FA''<br/>[A] | ||
! ''β-hydroxy FA'' <br/>[B] | |||
! ''esterified ω-hydroxy FA''<br/>[EO] | ! ''esterified ω-hydroxy FA''<br/>[EO] | ||
|- | |- | ||
| Line 133: | Line 128: | ||
| Cer-NDS | | Cer-NDS | ||
| Cer-ADS | | Cer-ADS | ||
| Cer-BDS | |||
| Cer-EODS | | Cer-EODS | ||
|- | |- | ||
| Line 138: | Line 134: | ||
| Cer-NS | | Cer-NS | ||
| Cer-AS | | Cer-AS | ||
| Cer-BS | |||
| Cer-EOS | | Cer-EOS | ||
|- | |- | ||
! ''phytosphingosine''<br/>[P] | ! ''phytosphingosine''<br/>[P] | ||
| Cer-NP | |||
| Cer-AP | | Cer-AP | ||
| Cer- | | Cer-BP | ||
| Cer-EOP | | Cer-EOP | ||
|- | |- | ||
| Line 148: | Line 146: | ||
| Cer-NH | | Cer-NH | ||
| Cer-AH | | Cer-AH | ||
| Cer-BH | |||
| Cer-EOH | | Cer-EOH | ||
|} | |} | ||
<references/> | <references/> | ||
Revision as of 08:31, 1 May 2019
Lipoquality
Dataset
Please click here to access LipoQuality data.
- Mouse
- C75BL/6J mouse fed with fish-less chow for 2 weeks
- Organs
- Aorta (ApoE KO), Brain, Heart, Kidney, Liver, Lung, Macrophage, Muscle, Plasma, Plasma (ApoE KO), Small intestine, Spleen
- Measurement
- See Metabolonote database.
Notation
The style follows the proposal for lipidomics nomenclature (Pauling JK et al. PLOS ONE 2017, PMID 29161304). Please visit the MS-DIAL page for more details.
|
|
- Ceramide symbols[1]
| non-hydroxy FA [N] |
α-hydroxy FA [A] |
β-hydroxy FA [B] |
esterified ω-hydroxy FA [EO] | |
|---|---|---|---|---|
| dihydrosphingosine [DS] |
Cer-NDS | Cer-ADS | Cer-BDS | Cer-EODS |
| sphingosine [S] |
Cer-NS | Cer-AS | Cer-BS | Cer-EOS |
| phytosphingosine [P] |
Cer-NP | Cer-AP | Cer-BP | Cer-EOP |
| 6-hydroxy sphingosine [H] |
Cer-NH | Cer-AH | Cer-BH | Cer-EOH |
- ↑ Masukawa Y et al. "Characterization of overall ceramide species in human stratum corneums" J Lipid Res 49:1466-1476, 2008
